CD86 and neoplasm: Future investigations should characterize macrophage subsets (such as iNOS/CD86 versus Arg1/CD206) using flow cytometry or multiplex immunostaining to determine whether macrophage-derived cytokines contribute to IL-6/STAT3 signaling during UVB-driven tumor promotion.